$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Onconetix, Inc. (NASDAQ: ONCO)

Core Viewpoint - Monteverde & Associates PC is investigating Onconetix, Inc. regarding its merger with Ocuvex Therapeutics, Inc., where Ocuvex shareholders will own approximately 90% of the combined company and Onconetix shareholders will own approximately 10% [1] Group 1 - Monteverde & Associates PC has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The proposed transaction involves an exchange of Ocuvex shares for Onconetix shares based on a defined exchange ratio [1] - The firm is headquartered in the Empire State Building, New York City [1] Group 2 - The firm emphasizes that it litigates and has a successful track record in trial and appellate courts, including the U.S. Supreme Court [2] - The firm offers free consultations for shareholders with concerns regarding the merger [3]